Browse Pet Safety Reports
18,010 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,010 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,010 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 26, 2024 | Horse | Friesian | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 26, 2024 | Horse | Quarter Horse | Flunixin Meglumine Injectable | Injection site swelling | Recovered/Normal |
| Mar 26, 2024 | Horse | Unknown | Sodium Hyaluronate | Injection site infection; No sign | Outcome Unknown |
| Mar 25, 2024 | Horse | Tennessee Walking Horse | Pergolide Mesylate | Ataxia; Head down | Recovered/Normal |
| Mar 25, 2024 | Horse | Pony of the Americas | Firocoxib | Abscess NOS | Outcome Unknown |
| Mar 25, 2024 | Horse | Connemara Pony | Polysulfated Glycosaminoglycan | Partial anorexia; Itching | Outcome Unknown |
| Mar 23, 2024 | Horse | Quarter Horse | Polysulfated Glycosaminoglycan | Tremor of limb; Tremor | Recovered/Normal |
| Mar 22, 2024 | Horse | Horse (unknown) | Firocoxib | Injection site swelling; Injection site abscess; Lameness | Ongoing |
| Mar 22, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Mar 21, 2024 | Horse | Horse (unknown) | Omeprazole | Colic; INEFFECTIVE, GASTRIC ULCER(S) | Recovered/Normal |
| Mar 21, 2024 | Horse | Quarter Horse | Clodronate Disodium | Colic; Flehmen response; Pawing | Recovered/Normal |
| Mar 20, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Mar 20, 2024 | Horse | Warmblood (unspecified) | Moxidectin | Colic; Digestive tract hypomotility | Recovered/Normal |
| Mar 20, 2024 | Horse | Standardbred (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 20, 2024 | Horse | Horse (unknown) | Ciclesonide | Behavioural disorder NOS; Device use issues NOS | Outcome Unknown |
| Mar 20, 2024 | Horse | Warmblood (unspecified) | Flunixin Meglumine Injectable | Colic; Digestive tract hypomotility | Recovered/Normal |
| Mar 19, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 19, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Mar 19, 2024 | Horse | Arab | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 19, 2024 | Horse | Thoroughbred | Ketamine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Mar 19, 2024 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 18, 2024 | Horse | Thoroughbred | Vit E/ Selenite Inj Solution | Shaking; Recumbency; Anaphylaxis; Death | Died |
| Mar 18, 2024 | Horse | Crossbred Equine/horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Mar 18, 2024 | Horse | Thoroughbred | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy | Outcome Unknown |
| Mar 18, 2024 | Horse | Holsteiner | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 17, 2024 | Horse | Horse (unknown) | Pergolide Mesylate | Anorexia | Outcome Unknown |
| Mar 16, 2024 | Horse | Quarter Horse | Equine Leucoreduced Allogeneic Pooled... | Hepatitis; Colic | Recovered/Normal |
| Mar 15, 2024 | Horse | Horse (unknown) | Firocoxib | Mouth ulcer; Intentional misuse | Outcome Unknown |
| Mar 15, 2024 | Horse | Arab | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 14, 2024 | Horse | Friesian | Pergolide Mesylate | Lack of efficacy - NOS; Hernia NOS | Ongoing |
| Mar 14, 2024 | Horse | Hanovarian | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 14, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Mar 13, 2024 | Horse | Paint | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Mar 13, 2024 | Horse | Quarter Horse | Ivermectin; Praziquantel | Application site swelling; Oral bleeding; Application site erythema; Nasal di... | Outcome Unknown |
| Mar 12, 2024 | Horse | Tennessee Walking Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Mar 12, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 12, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Mar 11, 2024 | Horse | Horse (unknown) | Dinoprost Tromethamine | Excessive sweating | Outcome Unknown |
| Mar 10, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Twitching; Injection site tenderness; Injection site stiffness | Outcome Unknown |
| Mar 9, 2024 | Horse | Quarter Horse | Omeprazole | Muscle tremor; Hyperkalaemia; Partial anorexia; Dehydration; Lethargy (see al... | Recovered/Normal |
| Mar 9, 2024 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site swelling | Recovered/Normal |
| Mar 6, 2024 | Horse | Thoroughbred | Pergolide Mesylate | Diarrhoea; Anorexia; Lethargy (see also Central nervous system depression in ... | Outcome Unknown |
| Mar 6, 2024 | Horse | Horse (unknown) | Pentosan Polysulfate Sodium | Injection site hair change | Outcome Unknown |
| Mar 6, 2024 | Horse | Standardbred (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 6, 2024 | Horse | Warmblood (unspecified) | Pergolide Mesylate | Slow heart rate; Pale mucous membrane; Colic; Elevated total bilirubin; Abdom... | Outcome Unknown |
| Mar 6, 2024 | Horse | Warmblood (unspecified) | Flunixin Meglumine Oral Paste | Slow heart rate; Pale mucous membrane; Colic; Elevated total bilirubin; Abdom... | Ongoing |
| Mar 6, 2024 | Horse | Quarter Horse | Polysulfated Glycosaminoglycan | Injection site swelling; Elevated serum amyloid A (SAA) | Outcome Unknown |
| Mar 5, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling; Fasciculation | Outcome Unknown |
| Mar 4, 2024 | Horse | Mustang | Pergolide Mesylate | Lethargy (see also Central nervous system depression in Neurological); Reluct... | Outcome Unknown |
| Mar 4, 2024 | Horse | Warmblood (unspecified) | Butorphanol Tartrate | Pawing; Increased sweating; Disorientation; Colic | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.